[go: up one dir, main page]

HK1115315B - 含有难溶活性成分的片剂 - Google Patents

含有难溶活性成分的片剂 Download PDF

Info

Publication number
HK1115315B
HK1115315B HK08109975.2A HK08109975A HK1115315B HK 1115315 B HK1115315 B HK 1115315B HK 08109975 A HK08109975 A HK 08109975A HK 1115315 B HK1115315 B HK 1115315B
Authority
HK
Hong Kong
Prior art keywords
tablet
active ingredient
hardly soluble
soluble active
preparation
Prior art date
Application number
HK08109975.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1115315A1 (zh
Inventor
Makoto Fukuta
Shigeyuki Marunaka
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Priority claimed from PCT/JP2006/312419 external-priority patent/WO2006137443A1/ja
Publication of HK1115315A1 publication Critical patent/HK1115315A1/zh
Publication of HK1115315B publication Critical patent/HK1115315B/zh

Links

HK08109975.2A 2005-06-22 2006-06-21 含有难溶活性成分的片剂 HK1115315B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005182415 2005-06-22
JP2005182415 2005-06-22
PCT/JP2006/312419 WO2006137443A1 (ja) 2005-06-22 2006-06-21 難溶性の有効成分を含有する錠剤

Publications (2)

Publication Number Publication Date
HK1115315A1 HK1115315A1 (zh) 2008-11-28
HK1115315B true HK1115315B (zh) 2011-08-26

Family

ID=

Similar Documents

Publication Publication Date Title
EP1049467B1 (en) Celecoxib compositions
EP2422783B1 (en) Pharmaceutical Composition
EP1900368B1 (en) Tablet containing hardly soluble active ingredient
EP1334732B1 (en) Pharmaceutical preparation of n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4 b]furan-8-yl)ethyl]propionamide coated with a copolyvidone-containing coating free of polyethylene glycol
EP0365480A1 (en) Dispersible formulation
EP0500851B1 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
KR101197277B1 (ko) 경구용 결핵의 치료용 또는 예방용 고형 제형
PL183678B1 (pl) Środek farmaceutyczny zawierający tiagabinę i sposób wytwarzania środka farmaceutycznego zawierającego tiagabinę
JP2722220B2 (ja) ピペリジノアルカノール誘導体の製剤組成物
HK1115315B (zh) 含有难溶活性成分的片剂
US5091191A (en) Pharmaceutical composition with improved dissolution property
JP4591726B2 (ja) メキタジン含有内服固形製剤
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
KR20070076388A (ko) 압축성형제제
US2914446A (en) Nitrite stabilized ascorbic acid-cyanocobalamin compositions
CA1209046A (en) Diuretic/antihypertensive compositions and methods of preparation
JP2006504696A (ja) インテグリン受容体アンタゴニストのマンニトール製剤
US11478432B2 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
CA2505139C (en) Oromucosal formulation and process for preparing the same
EP4649943A1 (en) Reduced nitrosamine formation in pharmaceutical compositions comprising methylphenidate
US20060222713A1 (en) Extended release pharmaceutical composition of phenytoin sodium
HK40038394A (zh) 抗凝物的即时释放药物制剂及其制备方法"
JPH07223952A (ja) 塩酸チザニジンを含有する無黄変性薬剤
WO2007067508A2 (en) Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
IE43611B1 (en) Antihypertonic agent